Synchron Buys French Biomarker, Dx Services Lab for $6.7M | GenomeWeb
NEW YORK (GenomeWeb News) - Indian clinical research organization Synchron Research Services has acquired from Parexel a biomarker and bioanalytical research facility based in France for around $6.7 million, Synchron said today.
 
The lab, which is located in Poitiers, France, and was bought by Parexel in 1999, will now be called Synexel Research International. The lab offers singleplexed and multiplexed immunoassay platforms that support early clinical, pre-clinical, and clinical studies, as well as biomarker research programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.